Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 9 studies | 48% ± 16% | |
mast cell | 6 studies | 38% ± 19% | |
microglial cell | 6 studies | 45% ± 16% | |
glutamatergic neuron | 6 studies | 40% ± 15% | |
GABAergic neuron | 5 studies | 33% ± 12% | |
endothelial cell | 5 studies | 37% ± 18% | |
conventional dendritic cell | 4 studies | 19% ± 6% | |
neuron | 4 studies | 29% ± 14% | |
retinal bipolar neuron | 4 studies | 60% ± 15% | |
interneuron | 4 studies | 35% ± 12% | |
macrophage | 4 studies | 51% ± 13% | |
dendritic cell | 4 studies | 37% ± 13% | |
brush cell | 4 studies | 37% ± 24% | |
ciliated cell | 3 studies | 29% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 36% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 1126.50 | 955 / 966 | 13% | 0.34 | 66 / 527 |
bladder | 100% | 661.05 | 21 / 21 | 6% | 0.16 | 29 / 504 |
pancreas | 100% | 1775.77 | 328 / 328 | 2% | 0.06 | 3 / 178 |
ovary | 100% | 1491.07 | 180 / 180 | 1% | 0.02 | 5 / 430 |
stomach | 86% | 433.38 | 307 / 359 | 15% | 0.41 | 44 / 286 |
kidney | 100% | 710.62 | 89 / 89 | 1% | 0.02 | 5 / 901 |
spleen | 100% | 756.93 | 241 / 241 | 0% | 0 | 0 / 0 |
prostate | 97% | 691.38 | 238 / 245 | 3% | 0.05 | 14 / 502 |
lung | 98% | 629.88 | 565 / 578 | 2% | 0.05 | 24 / 1155 |
thymus | 99% | 735.03 | 646 / 653 | 1% | 0.01 | 4 / 605 |
brain | 99% | 5145.23 | 2623 / 2642 | 0% | 0.01 | 1 / 705 |
liver | 99% | 1569.20 | 224 / 226 | 0% | 0.00 | 1 / 406 |
breast | 97% | 450.36 | 445 / 459 | 1% | 0.03 | 13 / 1118 |
adipose | 97% | 467.89 | 1162 / 1204 | 0% | 0 | 0 / 0 |
uterus | 95% | 496.76 | 162 / 170 | 1% | 0.02 | 4 / 459 |
adrenal gland | 95% | 568.79 | 246 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 80% | 487.19 | 1067 / 1335 | 0% | 0 | 0 / 0 |
heart | 70% | 540.37 | 601 / 861 | 0% | 0 | 0 / 0 |
esophagus | 63% | 291.81 | 912 / 1445 | 6% | 0.08 | 11 / 183 |
muscle | 44% | 317.87 | 357 / 803 | 0% | 0 | 0 / 0 |
skin | 36% | 112.55 | 660 / 1809 | 1% | 0.01 | 4 / 472 |
peripheral blood | 28% | 93.79 | 260 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0043087 | Biological process | regulation of GTPase activity |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | CHN2 |
Protein name | Chimaerin (Chimerin) Chimerin 2 Beta chimaerin isoform B2-CHNdel ex6p-12pB Beta chimaerin isoform B1-CHNdel ex7p-9 Beta chimaerin isoform B2-CHNdel ex3p-12pA Beta chimaerin isoform B1-CHNdel ex9,11 (Chimerin 2) Beta chimaerin isoform B1-CHNdel ex11-12 (Chimerin 2) Beta chimaerin isoform B1-CHNdel ex7p-8,11-12 Beta chimaerin isoform B2-CHNdel ex2-8,11-12 Beta chimaerin isoform B2-CHNdel ex4p-12pC CHN2 Beta chimaerin isoform B2-CHNdel ex6-11p Uncharacterized protein CHN2 Beta chimaerin isoform B1-CHNdel ex10-11 (Chimerin 2) Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3) Beta chimaerin isoform B2-CHNdel ex7p-13p Beta chimaerin isoform B2-CHNdel ex3 |
Synonyms | BCH ARHGAP3 |
Description | FUNCTION: GTPase-activating protein for p21-rac. Insufficient expression of beta-2 chimaerin is expected to lead to higher Rac activity and could therefore play a role in the progression from low-grade to high-grade tumors. FUNCTION: GTPase-activating protein for p21-rac. . FUNCTION: GTPase-activating protein for p21-rac. . FUNCTION: GTPase-activating protein for p21-rac. . |
Accessions | B3VCG5 ENST00000706158.1 ENST00000421775.6 [P52757-5] A0A994J535 A0A994J7L4 ENST00000412711.7 [P52757-3] B3VCF6 A0A994J5D1 B3VCF0 ENST00000706161.1 A0A994J7Z1 ENST00000446446.6 ENST00000409350.6 A0A994J5D6 ENST00000706162.1 ENST00000706160.1 H7C138 B3VCF5 B3VCG0 B7Z1V0 B3VCG4 A0A2X0TVW3 Q75MY2 A0A994J5R0 ENST00000222792.11 [P52757-1] B3VCE9 ENST00000433720.1 ENST00000467441.6 [P52757-4] P52757 ENST00000706159.1 B3VCG2 ENST00000706163.1 ENST00000409041.8 B3VCF9 H7C0V3 B3VCF8 B3VCF4 ENST00000439711.7 A0A994J7Z5 B3VCG3 ENST00000706164.1 ENST00000424025.5 |